BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 24304972)

  • 21. Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia.
    Ferrando AA; Neuberg DS; Staunton J; Loh ML; Huard C; Raimondi SC; Behm FG; Pui CH; Downing JR; Gilliland DG; Lander ES; Golub TR; Look AT
    Cancer Cell; 2002 Feb; 1(1):75-87. PubMed ID: 12086890
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hhex regulates Kit to promote radioresistance of self-renewing thymocytes in Lmo2-transgenic mice.
    Shields BJ; Alserihi R; Nasa C; Bogue C; Alexander WS; McCormack MP
    Leukemia; 2015 Apr; 29(4):927-38. PubMed ID: 25283843
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chromatin structural elements and chromosomal translocations in leukemia.
    Zhang Y; Rowley JD
    DNA Repair (Amst); 2006 Sep; 5(9-10):1282-97. PubMed ID: 16893685
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Extensive molecular mapping of TCRα/δ- and TCRβ-involved chromosomal translocations reveals distinct mechanisms of oncogene activation in T-ALL.
    Le Noir S; Ben Abdelali R; Lelorch M; Bergeron J; Sungalee S; Payet-Bornet D; Villarèse P; Petit A; Callens C; Lhermitte L; Baranger L; Radford-Weiss I; Grégoire MJ; Dombret H; Ifrah N; Spicuglia S; Romana S; Soulier J; Nadel B; Macintyre E; Asnafi V
    Blood; 2012 Oct; 120(16):3298-309. PubMed ID: 22948044
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A previously unrecognized promoter of LMO2 forms part of a transcriptional regulatory circuit mediating LMO2 expression in a subset of T-acute lymphoblastic leukaemia patients.
    Oram SH; Thoms JA; Pridans C; Janes ME; Kinston SJ; Anand S; Landry JR; Lock RB; Jayaraman PS; Huntly BJ; Pimanda JE; Göttgens B
    Oncogene; 2010 Oct; 29(43):5796-808. PubMed ID: 20676125
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SCL, LMO1 and Notch1 reprogram thymocytes into self-renewing cells.
    Gerby B; Tremblay CS; Tremblay M; Rojas-Sutterlin S; Herblot S; Hébert J; Sauvageau G; Lemieux S; Lécuyer E; Veiga DF; Hoang T
    PLoS Genet; 2014 Dec; 10(12):e1004768. PubMed ID: 25522233
    [TBL] [Abstract][Full Text] [Related]  

  • 27. FOXP3 can modulate TAL1 transcriptional activity through interaction with LMO2.
    Fleskens V; Mokry M; van der Leun AM; Huppelschoten S; Pals CE; Peeters J; Coenen S; Cardoso BA; Barata JT; van Loosdregt J; Coffer PJ
    Oncogene; 2016 Aug; 35(31):4141-8. PubMed ID: 26686090
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HOX-mediated LMO2 expression in embryonic mesoderm is recapitulated in acute leukaemias.
    Calero-Nieto FJ; Joshi A; Bonadies N; Kinston S; Chan WI; Gudgin E; Pridans C; Landry JR; Kikuchi J; Huntly BJ; Gottgens B
    Oncogene; 2013 Nov; 32(48):5471-80. PubMed ID: 23708655
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Site-specific deletions involving the tal-1 and sil genes are restricted to cells of the T cell receptor alpha/beta lineage: T cell receptor delta gene deletion mechanism affects multiple genes.
    Breit TM; Mol EJ; Wolvers-Tettero IL; Ludwig WD; van Wering ER; van Dongen JJ
    J Exp Med; 1993 Apr; 177(4):965-77. PubMed ID: 8459224
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structure of the leukemia oncogene LMO2: implications for the assembly of a hematopoietic transcription factor complex.
    El Omari K; Hoosdally SJ; Tuladhar K; Karia D; Vyas P; Patient R; Porcher C; Mancini EJ
    Blood; 2011 Feb; 117(7):2146-56. PubMed ID: 21076045
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The LIM protein RBTN2 and the basic helix-loop-helix protein TAL1 are present in a complex in erythroid cells.
    Valge-Archer VE; Osada H; Warren AJ; Forster A; Li J; Baer R; Rabbitts TH
    Proc Natl Acad Sci U S A; 1994 Aug; 91(18):8617-21. PubMed ID: 8078932
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tcf-1 promotes genomic instability and T cell transformation in response to aberrant β-catenin activation.
    Arnovitz S; Mathur P; Tracy M; Mohsin A; Mondal S; Quandt J; Hernandez KM; Khazaie K; Dose M; Emmanuel AO; Gounari F
    Proc Natl Acad Sci U S A; 2022 Aug; 119(32):e2201493119. PubMed ID: 35921443
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Two distinct mechanisms for the SCL gene activation in the t(1;14) translocation of T-cell leukemias.
    Bernard O; Guglielmi P; Jonveaux P; Cherif D; Gisselbrecht S; Mauchauffe M; Berger R; Larsen CJ; Mathieu-Mahul D
    Genes Chromosomes Cancer; 1990 Jan; 1(3):194-208. PubMed ID: 1964581
    [TBL] [Abstract][Full Text] [Related]  

  • 34. LIM domain only-2 (LMO2) induces T-cell leukemia by two distinct pathways.
    Smith S; Tripathi R; Goodings C; Cleveland S; Mathias E; Hardaway JA; Elliott N; Yi Y; Chen X; Downing J; Mullighan C; Swing DA; Tessarollo L; Li L; Love P; Jenkins NA; Copeland NG; Thompson MA; Du Y; Davé UP
    PLoS One; 2014; 9(1):e85883. PubMed ID: 24465765
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Screening for leukemia- and clone-specific markers at birth in children with T-cell precursor ALL suggests a predominantly postnatal origin.
    Fischer S; Mann G; Konrad M; Metzler M; Ebetsberger G; Jones N; Nadel B; Bodamer O; Haas OA; Schmitt K; Panzer-Grümayer ER
    Blood; 2007 Oct; 110(8):3036-8. PubMed ID: 17557895
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of genomic breakpoints in p190 and p210 BCR-ABL indicate distinct mechanisms of formation.
    Score J; Calasanz MJ; Ottman O; Pane F; Yeh RF; Sobrinho-Simões MA; Kreil S; Ward D; Hidalgo-Curtis C; Melo JV; Wiemels J; Nadel B; Cross NC; Grand FH
    Leukemia; 2010 Oct; 24(10):1742-50. PubMed ID: 20703256
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Notch1 inhibition targets the leukemia-initiating cells in a Tal1/Lmo2 mouse model of T-ALL.
    Tatarek J; Cullion K; Ashworth T; Gerstein R; Aster JC; Kelliher MA
    Blood; 2011 Aug; 118(6):1579-90. PubMed ID: 21670468
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activation of the
    Rahman S; Magnussen M; León TE; Farah N; Li Z; Abraham BJ; Alapi KZ; Mitchell RJ; Naughton T; Fielding AK; Pizzey A; Bustraan S; Allen C; Popa T; Pike-Overzet K; Garcia-Perez L; Gale RE; Linch DC; Staal FJT; Young RA; Look AT; Mansour MR
    Blood; 2017 Jun; 129(24):3221-3226. PubMed ID: 28270453
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Common chromatin structures at breakpoint cluster regions may lead to chromosomal translocations found in chronic and acute leukemias.
    Strick R; Zhang Y; Emmanuel N; Strissel PL
    Hum Genet; 2006 Jun; 119(5):479-95. PubMed ID: 16572268
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modeling T-cell acute lymphoblastic leukemia induced by the SCL and LMO1 oncogenes.
    Tremblay M; Tremblay CS; Herblot S; Aplan PD; Hébert J; Perreault C; Hoang T
    Genes Dev; 2010 Jun; 24(11):1093-105. PubMed ID: 20516195
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.